Does the CHER trial open up new therapeutic perspectives? [comment]

R. Colebunders, V. Musiime

Research output: Contribution to journal › Comment/debate › peer-review

Access to Document

@article{2145c3cdd1194775b02d8a936d604f63,

title = "Does the CHER trial open up new therapeutic perspectives? [comment]",

author = "R. Colebunders and V. Musiime",

note = "NPP; ITG-C1A; DCS; U-HIVCLI; JIF; DOI; PDF; DSPACE56; NOKW",

year = "2013",

doi = "10.1016/S0140-6736(13)61717-1",

language = "English",

volume = "382",

pages = "1539--1540",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9904",

}

TY - JOUR

T1 - Does the CHER trial open up new therapeutic perspectives? [comment]

AU - Colebunders, R.

AU - Musiime, V.

N1 - NPP; ITG-C1A; DCS; U-HIVCLI; JIF; DOI; PDF; DSPACE56; NOKW

PY - 2013

Y1 - 2013

U2 - 10.1016/S0140-6736(13)61717-1

DO - 10.1016/S0140-6736(13)61717-1

M3 - Comment/debate

C2 - 24209812

SN - 0140-6736

VL - 382

SP - 1539

EP - 1540

JO - Lancet

JF - Lancet

IS - 9904

ER -